Publisher： Adis International
ISSN： 1173-8324
Source： Inpharma, Vol.1, Iss.1407, 2003-01, pp. : 15-15
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
Natalizumab demonstrates efficacy in Crohn's disease . . .
Inpharma, Vol. 1, Iss. 1370, 2003-01 ,pp. :
Access to resources
Recommend
Clinical predictors at diagnosis of disabling pediatric Crohn's disease
By Savoye Guillaume Salleron Julia Gower-Rousseau Corinne Dupas Jean-Louis Vernier-Massouille Gwénola Fumery Mathurin Merle Véronique Lerebours Eric Cortot Antoine Turck Dominique Salomez Jean-Louis Lemann Marc Colombel Jean-Frédéric Duhamel Alain
Inflammatory Bowel Diseases, Vol. 18, Iss. 11, 2012-11 ,pp. :
Mucosal Healing in Crohn's Disease: Relevance for Clinical Outcomes
Current Drug Targets, Vol. 13, Iss. 10, 2012-09 ,pp. :
Clinical Pharmacokinetics of Leflunomide
By Rozman B.
Clinical Pharmacokinetics, Vol. 41, Iss. 6, 2002-01 ,pp. :